Anti-Phospho-MLK3 (Ser674) MAP3K11 Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Anti-Phospho-MLK3 (Ser674) MAP3K11 Antibody
Description:
Boster Bio Anti-Phospho-MLK3 (Ser674) MAP3K11 Antibody (Catalog # P04412) . Tested in WB, ELISA applications. This antibody reacts with Human, Mouse, Rat.Synonyms:
Mitogen-activated protein kinase kinase kinase 11;2.7.11.25; Mixed lineage kinase 3; Src-homology 3 domain-containing proline-rich kinase; MAP3K11 ; MLK3 , PTK1, SPRKGene Name:
MAP3K11UniProt:
Q16584Host:
RabbitReactivity:
Human, Mouse, RatImmunogen:
Synthesized peptide derived from human MLK3 around the phosphorylation site of S674.Clonality:
PolyclonalTissue Specificity:
Expressed in a wide variety of normal and neoplastic tissues including fetal lung, liver, heart and kidney, and adult lung, liver, heart, kidney, placenta, skeletal muscle, pancreas and brain. .Applications:
WB, ELISAField of Research:
Protein Phosphorylation, Ser/Thr Kinases, Signal Transduction, Tyrosine KinasesPurification:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.Concentration:
1 mg/mlForm:
LiquidFunction:
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. .Molecular Weight:
92688 MWShipping Conditions:
AvailableStorage Conditions:
Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.Other Gene Names:
Mitogen-activated protein kinase kinase kinase 11Subcellular Location:
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Location is cell cycle dependent.
